Last $84.55 USD
Change Today +0.01 / 0.01%
Volume 778.0K
AET On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:10 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

aetna inc (AET) Key Developments

Aetna Inc. Names Harold L. Paz as Executive Vice President and Chief Medical Officer

Aetna announced that Dr. Harold L. Paz will join the company later in July as executive vice president and chief medical officer (EVP/CMO). Paz will lead clinical strategy and policy at the intersection of all of Aetna's domestic and global businesses. Paz has served as chief executive officer of Penn State Milton S. Hershey Medical Center, Penn State's senior vice president for health affairs and dean of its College of Medicine since April 2006. Most recently, Paz led the negotiations between Penn State Hershey and PinnacleHealth toward the formation of a new integrated healthcare enterprise across central Pennsylvania.

Aetna Reportedly Selling Coventry Health's Assets

Aetna Inc. (NYSE:AET) is reportedly looking to sell assets of Coventry Health Care Inc. Aetna is reportedly working with Bank of America Merrill Lynch on a sale.

Aetna Elects Mark T. Bertolini as a Director; Approves Amendments to the Articles of Incorporation and By-Laws

On May 30, 2014, the shareholders of Aetna approved a proposal to amend Article 11 of the Company's Amended and Restated Articles of Incorporation to eliminate the supermajority voting provisions contained in the Articles of Incorporation and a proposal to amend Article 8(a) of the Articles of Incorporation to provide holders of at least 25% of the voting power of all outstanding shares the right to call a special meeting of shareholders, and the Company effected those amendments. On May 30, 2014, the shareholders of company also approved a proposal to amend Section 5.02 of the Company's Amended and Restated By-Laws to eliminate the supermajority voting provisions contained in the By-Laws. Also on May 30, 2014, following the effectiveness of the amendment to Article 8(a) of the Articles of Incorporation, the company's Board of Directors amended Sections 1.03 and 1.04 of the By-Laws to address procedural issues in connection with the exercise of the shareholders' right to call a special meeting of shareholders. In addition, on May 30, 2014, the Board amended Section 4.01 of the By-Laws to eliminate the second sentence of such Section 4.01 (regarding appointment of certain officers), which was determined to be unnecessary. The shareholders also elected the director nominee Mark T. Bertolini as a director of the company until the next Annual Meeting and until their successors are duly elected.

Aetna Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 10:00 AM

Aetna Inc. Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-11-2014 10:00 AM. Venue: Terranea Resort in Rancho Palos Verdes, 100 Terranea Way, Los Angeles, California, United States. Speakers: Mark T. Bertolini, Chairman, Chief Executive Officer, President, Chairman of Executive Committee, Member of Investment & Finance Committee and Member of Investment & Finance Committee.

Aetna Inc. Declares Quarterly Cash Dividend, Payable on July 25, 2014

The Board of Directors of Aetna Inc. declared a quarterly cash dividend of $0.225 per share on the company's common stock. The dividend is payable on July 25, 2014, to shareholders of record at the close of business on July 10, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AET:US $84.60 USD +0.06

AET Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aflac Inc $63.97 USD +0.38
Cigna Corp $97.03 USD +0.23
Humana Inc $133.84 USD +0.78
Prudential Financial Inc $89.88 USD -0.425
WellPoint Inc $115.63 USD +0.19
View Industry Companies
 

Industry Analysis

AET

Industry Average

Valuation AET Industry Range
Price/Earnings 14.9x
Price/Sales 0.6x
Price/Book 2.1x
Price/Cash Flow 12.9x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AETNA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.